Oral anticoagulants - The old and the new

被引：3

作者：

Ansell, J ^{[1
]}

机构：

[1] Boston Univ, Sch Med, Boston, MA 02215 USA

[2] Boston Univ, Med Ctr, Dept Med, Boston, MA USA

来源：

DM DISEASE-A-MONTH | 2005年 / 51卷 / 2-3期

关键词：

D O I：

10.1016/j.disamonth.2005.03.017

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：208 / 212

页数：5

共 18 条

[1]

Ansell Jack, 2004, Curr Hematol Rep, V3, P357

[2] The quality of anticoagulation management [J].

Ansell, JE .

ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (07) :895-896

[3]

ANSELL JE, 1998, J THROMB THROMBOLY S, V5, pS13

[4] Fondaparinux or Enoxaparin for the initial treatment of symptomatic deep venous thrombosis -: A randomized trial [J].

Büller, HR ;

Davidson, BL ;

Decousus, H ;

Gallus, A ;

Gent, M ;

Piovella, F ;

Prins, MH ;

Raskob, G ;

Segers, AEM ;

Cariou, R ;

Leeuwenkamp, O ;

Lensing, AWA .

ANNALS OF INTERNAL MEDICINE, 2004, 140 (11) :867-873

[5]

Büller HR, 2003, NEW ENGL J MED, V349, P1695

[6] Heparin-induced thrombocytopenia [J].

Chong, BH .

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2003, 1 (07) :1471-1478

[7] Ximelagatran: the first oral direct thrombin inhibitor [J].

Crowther, MA ;

Weitz, JI .

EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2004, 13 (04) :403-413

[8] Ximelagatran/melagatran - A review of its use in the prevention of venous thromboembolism in orthopaedic surgery [J].

Evans, HC ;

Perry, CM ;

Faulds, D .

DRUGS, 2004, 64 (06) :649-678

[9]

Francis CW, 2003, BLOOD, V102, p6A

[10] Ximelagatran or warfarin for stroke prevention in patients with atrial fibrillation? [J].

Hankey, GJ ;

Klijn, CJM ;

Eikelboom, JW .

STROKE, 2004, 35 (02) :389-391

← 1 2 →